Summary by Moomoo AI
RedHill Biopharma Ltd., an Israeli-incorporated company, has announced a change in the ratio of its Shares per American Depositary Share (ADS), effective August 22, 2024. The new ratio will be one ADS to ten thousand shares, a significant increase from the previous four hundred shares per ADS. This change was filed under Rule 424(b)(3) with the file number 333-268713. The Bank of New York Mellon, acting as the depositary, certifies ownership of the ADSs, which are now adjusted to represent 10,000 deposited ordinary shares of RedHill Biopharma. The detailed terms and conditions of the American Depositary Receipts (ADRs) are set forth in the deposit agreement dated December 26, 2012, which outlines the rights and obligations of the ADS owners and the depositary. The agreement also...Show More